Avocats Paris, Toulouse - cLé réseau d'avocats - Christophe Leguevaques, Romain Sintès
Accueil
Envoyer à un ami
Version imprimable

TRAINING + RESEARCH + HEALTHCARE + INDUSTRY : THIS IS THE ONCOPOLE


The Oncopole is the only site in Europe that brings together both researchers, academics, physicians, patients and – the distinctive feature of the Toulouse site - companies of all sizes: start-ups, SMEs and major industrial partners.



TRAINING + RESEARCH + HEALTHCARE + INDUSTRY : THIS IS THE ONCOPOLE

THE STRENGTH OF THE ONCOPOLE, a radically new pooling of expertise


This proximity between the different players creates a true «campus effect.» Here we work side by side, we mix knowledge, increase collaborations that allow innovative ideas to emerge. The mission of this «research / training / healthcare / industry» continuum is clear: speed up the discovery of new treatments, reduce the waiting periods between research and clinical applications, and offer patients more personalized and more effective therapies to fight cancer.

In 2014, the Oncopole includes 4,000 people, brought together on the same campus, and 2,400 public and private researchers.


TRAINING + RESEARCH + HEALTHCARE + INDUSTRY : THIS IS THE ONCOPOLE

THE SCIENTIFIC AND TECHNOLOGICAL RESOURCES OF TOULOUSE MAKE UP THE WEALTH OF THE ONCOPOLE


THE AMBITION OF THE ONCOPOLE : make Toulouse a reference on a European scale

With a comprehensive and innovative approach in the fight against cancer, based on the potential of enriching the scientific and technological expertise of Toulouse, the Oncopole has the necessary assets to become a national and European reference and create the diagnostics and drugs of tomorrow.

TRAINING + RESEARCH + HEALTHCARE + INDUSTRY : THIS IS THE ONCOPOLE

A QUALITATIVE APPROACH TO SUPPORTING INNOVATION

THE FOUNDATION’S MISSION is to support the development of innovative treatments

Toulouse Cancer Health Foundation identifies, finances and supports innovative research programs in the fight against cancer.

To optimize its funding, the Foundation has chosen to focus on a limited number of programs with high potential, and support them at a high financial level (€ 600,000 on average). It operates from the discovery phase to the technological development with the ambition to lead the best projects to clinical trials within the Oncopole.
Since its inception, it has supported 10 research programs involving the combination of state-of-the-art technologies: nanotechnology, biotechnology and info-technology.




TRAINING + RESEARCH + HEALTHCARE + INDUSTRY : THIS IS THE ONCOPOLE

BY POOLING EVERYONE’S EFFORTS, DONATIONS BECOME EXPONENTIAL

One person’s contribution is not enough to beat cancer. But together, each individual effort is strengthened and can make a real difference. Thus each Oncopole ambassador donates € 1,000 (or more ...) and then finds 3 donors who in turn become ambassadors to spread the word to three other people, and so on.

1 donation turns into 3, 3 donations turn into nine, and soon we reach thousands of donations.

This exponential donation includes events such as dinners to induct new ambassadors and allow them to meet the physicians and researchers at the Oncopole.

TRAINING + RESEARCH + HEALTHCARE + INDUSTRY : THIS IS THE ONCOPOLE




Mécénat | Pro bono | RSE (Responsabilité Sociale des Entreprises)